Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
University of Oxford NHS Cancer Screening Programmes Department of Health |
---|---|
Information provided by: | University of Oxford |
ClinicalTrials.gov Identifier: | NCT00890864 |
The purpose of this pilot study is to assess the feasibility and acceptability of randomising the phasing-in of the age extension of the NHS Breast Screening Programme in six volunteer sites in different areas of England.
Condition | Intervention |
---|---|
Routine Mammography |
Other: Invitation for breast screening |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Open Label, Parallel Assignment |
Official Title: | Pilot Study of the Feasibility and Acceptability of Randomising the Phasing-in of the Age Extension of the NHS Breast Screening Programme in England |
Estimated Enrollment: | 36000 |
Study Start Date: | May 2009 |
Estimated Study Completion Date: | May 2010 |
Estimated Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Active Comparator
Women aged 47-49 invited for breast screening
|
Other: Invitation for breast screening
Invitation for breast screening to women in different age groups
|
2: Active Comparator
Women aged 71-73 invited for breast screening
|
Other: Invitation for breast screening
Invitation for breast screening to women in different age groups
|
Currently all women are invited for breast screening between the ages of 50 and 70. In 2007 the Cancer Reform Strategy announced that from 2012 the NHS Breast Screening Programme would be extended to cover women between the ages of 47 and 73. This means that all women will get two extra screening invitations in their lifetime. It also means that all women will get their first invitation before age 50. As capacity does not allow for full immediate roll out across the whole of England, the age extension will be phased-in with full coverage from 2012. Randomising this phasing-in would provide unbiased evidence on the extent to which it is beneficial to extend the age range for breast screening and whether an extra screen at younger or older ages is more worthwhile. To date there is no clear evidence on this as no trial has looked at the added value of one extra screen within an existing screening programme. This pilot study will assess the feasibility and acceptability of randomising the phasing-in of the age extension in six volunteer sites in different areas of England.
Ages Eligible for Study: | 47 Years to 73 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Principal Investigator: | Julietta Patnick, BA (Hons) | NHS Cancer Screening Programmes; also, Oxford University |
Responsible Party: | Clinical Trials and Research Governance, Oxford University ( Heather House ) |
Study ID Numbers: | 09/H0710/2, ISRCTN50037017 |
Study First Received: | January 26, 2009 |
Last Updated: | April 29, 2009 |
ClinicalTrials.gov Identifier: | NCT00890864 History of Changes |
Health Authority: | United Kingdom: Research Ethics Committee |
Breast screening Mammogram Routine screening programme |